$UTHR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNITED THERAPEUTICS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UNITED THERAPEUTICS Corp. Get notifications about new insider transactions in UNITED THERAPEUTICS Corp for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 58 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 120.40 | 642 | 77,298 | 759 | 1.4 K to 759 (-45.82 %) |
May 22 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 915 | 28,136 | 657,529 | 656.6 K to 657.5 K (+0.14 %) |
May 22 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,261 | 38,776 | 1,401 | 140 to 1.4 K (+900.71 %) |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 918 | 28,229 | 63,119 | |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,259 | 38,714 | 64,037 | |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 918 | 28,229 | 656,614 | 655.7 K to 656.6 K (+0.14 %) |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 122.45 | 312 | 38,203 | 140 | 452 to 140 (-69.03 %) |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 121.85 | 947 | 115,396 | 452 | 1.4 K to 452 (-67.69 %) |
May 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,259 | 38,714 | 1,399 | 140 to 1.4 K (+899.29 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 918 | 28,229 | 65,296 | |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,258 | 38,684 | 66,214 | |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 122.75 | 314 | 38,542 | 140 | 454 to 140 (-69.16 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 122.07 | 944 | 115,233 | 454 | 1.4 K to 454 (-67.53 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 918 | 28,229 | 655,696 | 654.8 K to 655.7 K (+0.14 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,258 | 38,684 | 1,398 | 140 to 1.4 K (+898.57 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 11,250 | |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 51.77 | 500 | 25,885 | 500 | |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 122.32 | 750 | 91,740 | 975 | 1.7 K to 975 (-43.48 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 1,725 | 975 to 1.7 K (+76.92 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 122.32 | 500 | 61,160 | 975 | 1.5 K to 975 (-33.90 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 51.77 | 500 | 25,885 | 1,475 | 975 to 1.5 K (+51.28 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 20,500 | |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 122.32 | 6,000 | 733,920 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
May 05 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |
Apr 28 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 915 | 28,136 | 67,472 | |
Apr 28 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,262 | 38,807 | 68,387 | |
Apr 28 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 915 | 28,136 | 654,778 | 653.9 K to 654.8 K (+0.14 %) |
Apr 28 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 120.78 | 1,262 | 152,422 | 140 | 1.4 K to 140 (-90.01 %) |
Apr 28 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,262 | 38,807 | 1,402 | 140 to 1.4 K (+901.43 %) |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 916 | 28,167 | 69,649 | |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,260 | 38,745 | 70,565 | |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 916 | 28,167 | 653,863 | 652.9 K to 653.9 K (+0.14 %) |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 121.14 | 1,260 | 152,633 | 140 | 1.4 K to 140 (-90.00 %) |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,260 | 38,745 | 1,400 | 140 to 1.4 K (+900.00 %) |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 26,500 | |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 121.21 | 6,000 | 727,260 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
Apr 21 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |
Apr 14 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 919 | 28,259 | 71,825 | |
Apr 14 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,258 | 38,684 | 72,744 | |
Apr 14 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 919 | 28,259 | 652,947 | 652 K to 652.9 K (+0.14 %) |
Apr 14 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 122.12 | 1,258 | 153,625 | 140 | 1.4 K to 140 (-89.99 %) |
Apr 14 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,258 | 38,684 | 1,398 | 140 to 1.4 K (+898.57 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 919 | 28,259 | 74,002 | |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,257 | 38,653 | 74,921 | |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 919 | 28,259 | 652,028 | 651.1 K to 652 K (+0.14 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 123.08 | 400 | 49,231 | 140 | 540 to 140 (-74.07 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 122.07 | 857 | 104,617 | 540 | 1.4 K to 540 (-61.35 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,257 | 38,653 | 1,397 | 140 to 1.4 K (+897.86 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 32,500 | |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 122.00 | 6,000 | 732,000 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 12,000 | |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 51.77 | 500 | 25,885 | 1,000 | |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 122.00 | 750 | 91,500 | 975 | 1.7 K to 975 (-43.48 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 1,725 | 975 to 1.7 K (+76.92 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 122.00 | 500 | 61,000 | 975 | 1.5 K to 975 (-33.90 %) |
Apr 10 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 51.77 | 500 | 25,885 | 1,475 | 975 to 1.5 K (+51.28 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 947 | 29,120 | 76,178 | |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,230 | 37,823 | 77,125 | |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 947 | 29,120 | 651,109 | 650.2 K to 651.1 K (+0.15 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 135.27 | 230 | 31,111 | 140 | 370 to 140 (-62.16 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 134.57 | 900 | 121,116 | 370 | 1.3 K to 370 (-70.87 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 132.82 | 100 | 13,282 | 1,270 | 1.4 K to 1.3 K (-7.30 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,230 | 37,823 | 1,370 | 140 to 1.4 K (+878.57 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 957 | 29,428 | 78,355 | |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,219 | 37,484 | 79,312 | |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 957 | 29,428 | 650,162 | 649.2 K to 650.2 K (+0.15 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 139.86 | 500 | 69,930 | 140 | 640 to 140 (-78.12 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 138.96 | 719 | 99,912 | 640 | 1.4 K to 640 (-52.91 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,219 | 37,484 | 1,359 | 140 to 1.4 K (+870.71 %) |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Option Exercise | M | 54.77 | 2,000 | 109,540 | 13,000 | |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Sell | S | 139.37 | 2,000 | 278,740 | 0 | 2 K to 0 (-100.00 %) |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Buy | M | 54.77 | 2,000 | 109,540 | 2,000 | 0 to 2 K |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 38,500 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 139.11 | 6,000 | 834,660 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 959 | 29,489 | 80,531 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,218 | 37,454 | 81,490 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 959 | 29,489 | 649,205 | 648.2 K to 649.2 K (+0.15 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 144.16 | 100 | 14,416 | 140 | 240 to 140 (-41.67 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 141.87 | 200 | 28,374 | 240 | 440 to 240 (-45.45 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 140.62 | 300 | 42,185 | 440 | 740 to 440 (-40.54 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 139.27 | 300 | 41,780 | 740 | 1 K to 740 (-28.85 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 138.22 | 318 | 43,954 | 1,040 | 1.4 K to 1 K (-23.42 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,218 | 37,454 | 1,358 | 140 to 1.4 K (+870.00 %) |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | A | 146.03 | 240,000 | 35,047,200 | 240,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | A | 146.03 | 75,000 | 10,952,250 | 75,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | EDGEMOND JAMES | CFO and Treasurer | Option Exercise | A | 146.03 | 45,000 | 6,571,350 | 45,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | BENKOWITZ MICHAEL | President and COO | Option Exercise | A | 146.03 | 63,000 | 9,199,890 | 63,000 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Option Exercise | M | 48.11 | 3,000 | 144,330 | 0 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Sell | D | 146.44 | 3,000 | 439,320 | 0 | 3 K to 0 (-100.00 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Buy | M | 48.11 | 3,000 | 144,330 | 3,000 | 0 to 3 K |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 970 | 29,828 | 82,708 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,206 | 37,085 | 83,678 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 970 | 29,828 | 648,246 | 647.3 K to 648.2 K (+0.15 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 147.85 | 200 | 29,570 | 140 | 340 to 140 (-58.82 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 146.91 | 700 | 102,837 | 340 | 1 K to 340 (-67.31 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 145.56 | 306 | 44,542 | 1,040 | 1.3 K to 1 K (-22.73 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,206 | 37,085 | 1,346 | 140 to 1.3 K (+861.43 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 12,750 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 51.77 | 500 | 25,885 | 1,500 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 147.19 | 750 | 110,393 | 975 | 1.7 K to 975 (-43.48 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 1,725 | 975 to 1.7 K (+76.92 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 147.19 | 500 | 73,595 | 975 | 1.5 K to 975 (-33.90 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 51.77 | 500 | 25,885 | 1,475 | 975 to 1.5 K (+51.28 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 44,500 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 147.19 | 6,000 | 883,140 | 35,221 | 41.2 K to 35.2 K (-14.56 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,221 | 35.2 K to 41.2 K (+17.04 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 968 | 29,766 | 87,061 | |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,208 | 37,146 | 88,029 | |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 145.64 | 400 | 58,255 | 140 | 540 to 140 (-74.07 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 146.76 | 308 | 45,201 | 540 | 848 to 540 (-36.32 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 144.57 | 200 | 28,914 | 848 | 1 K to 848 (-19.08 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 143.29 | 300 | 42,986 | 1,048 | 1.3 K to 1 K (-22.26 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 968 | 29,766 | 646,302 | 645.3 K to 646.3 K (+0.15 %) |
Feb 24 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,208 | 37,146 | 1,348 | 140 to 1.3 K (+862.86 %) |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 50,500 | |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 168.42 | 6,000 | 1,010,520 | 35,221 | 41.2 K to 35.2 K (-14.56 %) |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,221 | 35.2 K to 41.2 K (+17.04 %) |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,004 | 30,873 | 89,237 | |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,173 | 36,070 | 90,241 | |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 167.92 | 1,173 | 196,966 | 140 | 1.3 K to 140 (-89.34 %) |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,004 | 30,873 | 645,334 | 644.3 K to 645.3 K (+0.16 %) |
Feb 17 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,173 | 36,070 | 1,313 | 140 to 1.3 K (+837.86 %) |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 998 | 30,689 | 91,414 | |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,178 | 36,224 | 92,412 | |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 164.90 | 678 | 111,803 | 140 | 818 to 140 (-82.89 %) |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 164.20 | 400 | 65,680 | 818 | 1.2 K to 818 (-32.84 %) |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 162.64 | 100 | 16,264 | 1,218 | 1.3 K to 1.2 K (-7.59 %) |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 998 | 30,689 | 644,330 | 643.3 K to 644.3 K (+0.16 %) |
Feb 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,178 | 36,224 | 1,318 | 140 to 1.3 K (+841.43 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 996 | 30,627 | 93,590 | |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,181 | 36,316 | 94,586 | |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 163.26 | 601 | 98,116 | 140 | 741 to 140 (-81.11 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 162.00 | 580 | 93,959 | 741 | 1.3 K to 741 (-43.91 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 996 | 30,627 | 643,332 | 642.3 K to 643.3 K (+0.16 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,181 | 36,316 | 1,321 | 140 to 1.3 K (+843.57 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 56,500 | |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 165.10 | 6,000 | 990,600 | 35,221 | 41.2 K to 35.2 K (-14.56 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,221 | 35.2 K to 41.2 K (+17.04 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 13,500 | |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 51.77 | 500 | 25,885 | 2,000 | |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 165.10 | 750 | 123,825 | 975 | 1.7 K to 975 (-43.48 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 165.10 | 500 | 82,550 | 1,725 | 2.2 K to 1.7 K (-22.47 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 2,225 | 1.5 K to 2.2 K (+50.85 %) |
Feb 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 51.77 | 500 | 25,885 | 1,475 | 975 to 1.5 K (+51.28 %) |
Jan 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 990 | 30,443 | 95,767 | |
Jan 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,186 | 36,470 | 96,757 | |
Jan 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 990 | 30,443 | 642,336 | 641.3 K to 642.3 K (+0.15 %) |
Jan 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | D | 161.14 | 100 | 16,114 | 140 | 240 to 140 (-41.67 %) |